Homofenazine

This classification denotes a sedative and hypnotic with the molecular formula C23H28F3N3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PEL7G6VRZ2, chemically known as 2-trifluoroethyl-10-(3-(4-(beta-hydroxyethyl-1-hexahydro-1,4-diazepinyl)propyl)phenothiazine but generally known as homofenazine, which bears US NIH Compound Identifier 19687. European Medicines Agency schedules Homofenazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08051MIG. The term HOMOFENAZINE is an International Non-Proprietary Name. HOMOFENAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule homofenazine under HS 29343090 and SITC 51578. As of Q4 2014, HOMOFENAZINE remains the US FDA Preferred Term for this commodity. Homofenazine bears US NLM identifiers UMLS ID C2825301 and NCI Concept Code C80674. SMILES: S1C2C(N(CCCN3CCCN(CC3)CCO)C3C1CCCC3)CC(CC2)C(F)(F)F.